Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026)
Rigel Pharmaceuticals' quarterly Current Leases came in at $636000.0 in Q1 2026, up 39.47% year-on-year from $456000.0 in Q1 2025, and up 3.58% quarter-over-quarter from $614000.0 in Q4 2025.
Rigel Pharmaceuticals has reported Current Leases for 15 years, with the latest figure at $636000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 39.47% year-over-year to $636000.0; the trailing twelve-month figure through Mar 2026 stood at $636000.0 (up 39.47% YoY), and the FY2025 full-year result was $614000.0, up 115.44% from the prior year.
- Current Leases for Q1 2026 stood at $636000.0, up from $614000.0 in the prior quarter.
- The five-year high for Current Leases was $8.3 million in Q1 2022, with the low at $285000.0 in Q4 2024.
- Average Current Leases over 5 years is $1.5 million, with a median of $636000.0 recorded in 2026.
- Year-over-year, Current Leases plunged 94.59% in 2023 and surged 115.44% in 2025.
- Tracing RIGL's Current Leases over 5 years: stood at $1.1 million in 2022, then plunged by 38.92% to $692000.0 in 2023, then slumped by 58.82% to $285000.0 in 2024, then surged by 115.44% to $614000.0 in 2025, then advanced by 3.58% to $636000.0 in 2026.
- The last three Current Leases figures came in at $636000.0 (Q1 2026), $614000.0 (Q4 2025), and $594000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 636,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 614,000.00 |
| Sep 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 517,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 466,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 692,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 449,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 9.89 Mn |
| Sep 30, 2021 | 9.57 Mn |
| Jun 30, 2021 | 9.22 Mn |
| Mar 31, 2021 | 8.92 Mn |
| Dec 31, 2020 | 8.62 Mn |
| Sep 30, 2020 | 8.33 Mn |
| Jun 30, 2020 | 8.05 Mn |
| Mar 31, 2020 | 7.78 Mn |
| Dec 31, 2019 | 7.27 Mn |
| Sep 30, 2019 | 7.26 Mn |
| Jun 30, 2019 | 7.00 Mn |
| Mar 31, 2019 | 5.24 Mn |
| Dec 31, 2018 | 3.60 Mn |
| Dec 31, 2017 | 284,000.00 |
| Sep 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | 2.20 Mn |
| Mar 31, 2017 | 3.13 Mn |
| Dec 31, 2016 | 3.22 Mn |
| Sep 30, 2016 | 3.17 Mn |
| Jun 30, 2016 | 3.11 Mn |
| Mar 31, 2016 | 3.06 Mn |
| Dec 31, 2015 | 3.01 Mn |
| Sep 30, 2015 | 2.95 Mn |
| Jun 30, 2015 | 2.90 Mn |
| Mar 31, 2015 | 2.85 Mn |
| Dec 31, 2014 | 2.80 Mn |
| Sep 30, 2011 | 134,000.00 |
| Jun 30, 2011 | 315,000.00 |
| Dec 31, 2010 | 755,000.00 |